LUMO — Lumos Pharma Share News
0.000.00%
Last trade - 00:00- $37.41m
- $23.89m
- $2.05m
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)
Brief: Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024
Lumos Pharma Inc reports results for the quarter ended in June - Earnings Summary
Lumos Pharma Inc expected to post a loss of $1.24 a share - Earnings Preview
Brief: Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
Lumos Pharma Inc expected to post a loss of $1.18 a share - Earnings Preview
Lumos Pharma Inc expected to post a loss of $1.18 a share - Earnings Preview
Lumos Pharma Inc reports results for the quarter ended in December - Earnings Summary
Lumos Pharma Inc expected to post a loss of $1.15 a share - Earnings Preview
Lumos Pharma Inc reports results for the quarter ended in June - Earnings Summary
Lumos Pharma Inc expected to post a loss of $1.10 a share - Earnings Preview
Brief: Lumos Pharma Announces Departure Of Chief Medical Officer
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
Brief: Daniel Farb Reports 7.87% Stake In Lumos Pharma As Of May 24, 2023
Lumos Pharma Inc reports results for the quarter ended in March - Earnings Summary
Brief: Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical Updates